- Home
- ECCF vs TXMD Comparison
ECCF vs TXMD Comparison
Compare ECCF & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECCF
- TXMD
- Stock Information
- Founded
- ECCF N/A
- TXMD 2008
- Country
- ECCF
- TXMD United States
- Employees
- ECCF N/A
- TXMD N/A
- Industry
- ECCF
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- ECCF
- TXMD Health Care
- Exchange
- ECCF NYSE
- TXMD Nasdaq
- Market Cap
- ECCF N/A
- TXMD 12.8M
- IPO Year
- ECCF N/A
- TXMD N/A
- Fundamental
- Price
- ECCF $25.04
- TXMD $1.19
- Analyst Decision
- ECCF
- TXMD
- Analyst Count
- ECCF 0
- TXMD 0
- Target Price
- ECCF N/A
- TXMD N/A
- AVG Volume (30 Days)
- ECCF N/A
- TXMD 44.6K
- Earning Date
- ECCF N/A
- TXMD 08-11-2025
- Dividend Yield
- ECCF N/A
- TXMD N/A
- EPS Growth
- ECCF N/A
- TXMD N/A
- EPS
- ECCF N/A
- TXMD N/A
- Revenue
- ECCF N/A
- TXMD $1,841,000.00
- Revenue This Year
- ECCF N/A
- TXMD $427.09
- Revenue Next Year
- ECCF N/A
- TXMD N/A
- P/E Ratio
- ECCF N/A
- TXMD N/A
- Revenue Growth
- ECCF N/A
- TXMD 53.55
- 52 Week Low
- ECCF N/A
- TXMD $0.70
- 52 Week High
- ECCF N/A
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- ECCF 57.39
- TXMD 49.81
- Support Level
- ECCF $24.88
- TXMD $0.98
- Resistance Level
- ECCF $25.13
- TXMD $1.21
- Average True Range (ATR)
- ECCF 0.10
- TXMD 0.09
- MACD
- ECCF 0.00
- TXMD 0.01
- Stochastic Oscillator
- ECCF 63.33
- TXMD 82.48
About ECCF EAGLE POINT CREDIT COMPANY INC 8.00 CONV PREF SERIES A
Eagle Point Credit Co Inc. is an externally managed, non-diversified closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective of capital appreciation. The Company seeks to achieve its investment objectives by investing in equity and junior debt tranches of collateralized loan obligations ("CLOs") collateralized by a portfolio consisting of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. The Company intends to operate so as to qualify to be taxed as a regulated investment company.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.